Safe employment of recombinant human erythropoietin in pregnancy in two anuric patients on regular dialysis treatment.
Rocca
A R
AR
Chair of Nephrology, University La Sapienza, Rome, Italy.
Mazzaferro
S
S
Stirati
G
G
Bilancioni
E
E
Giorlandino
C
C
D000328:Adult; D000740:Anemia / Q000628:therapy; D001002:Anuria / Q000628:therapy*; D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000628:therapy
D011994:Recombinant Proteins; D004921:Erythropoietin